Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04945148
Title Oxidative Phosphorylation Targeting In Malignant Glioma Using Metformin Plus Radiotherapy Temozolomide (OPTIMUM)
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Hopital Foch
Indications

IDH-wildtype glioblastoma

Therapies

Metformin + Temozolomide

Age Groups: adult | senior
Covered Countries ITA | FRA

Facility Status City State Zip Country Details
Foch Hospital Suresnes Hauts De Seine 92150 France Details
Hôpital Neurologique Pierre Wertheimer Bron Lyon 69500 France Details
Timone Hospital Marseille 13354 France Details
Saint Louis Hospital Paris 75010 France Details
Pitié Salpêtrière Hospital Paris 75013 France Details
Istituto Nazionale Carlo Besta Milano 20131 Italy Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field